Navigation Links
Bipolar Risk Gene Identified

Bipolar disorder is otherwise called as maniac-depressive illness. The disease incidence is about one in fifty. But the sad state is that one in six people who suffer from the disorder are likely to commit suicide.//

Hence extensive research was done on this disease to identify the gene and also develop various treatment modalities. Dr. Ian Blair conducted a study which revealed the bipolar risk gene.

The research was collaborative effort from both the Garvan Institute of Medical Research and University of New South Wales. This research would help many patients suffering from this disorder as it shows that certain people who have this gene are at a higher risk of developing Bipolar disorder.

Dr. Ian Blair published his work in the journal molecular psychiatry. They studied a wide rage of people including unrelated patients, and therapeutic drug mouse models and a large number of samples.

At the end they found that the gene responsible to increase the risk of this disorder to be the FAT gene. It codes for proteins which connect the brain cells.

But the exact mechanism of how the gene (FAT) increases the risk of developing bipolar disorder is still a mystery which has to be unraveled by conducting further research.

The treatment of this disorder is usually lithium. Lithium is apparently the first mood-stabilizing agent approved by the U.S. Food and Drug Administration (FDA).

But the mode of action of lithium is not yet understood in detail. Lithium also has few disadvantages like weight gain, kidney problems, tremor etc.

Dr Blair’s reports that lithium alters the FAT gene and its expression along with the other FAT proteins associated in increasing the risk of bipolar disorder.

In conclusion the scientist tells that further research is necessary to identify the mode of action of the FAT gene and develop new medicines that have no side-effects as lithium.


'"/>




Related medicine news :

1. Psychosocial Disability Varies In Accordance With Bipolar Symptom Changes
2. Seroquel to Treat Depression In Case Of Bipolar Disorder
3. Researchers Identify Gene Connected To Bipolar Disorder
4. Mood Stabilizing drugs for Bipolar disorder
5. Bipolar Disorder Not Being Accurately Diagnosed By Doctors In UK
6. Promising Care Model For Bipolar Disorder
7. Research on Bipolar Disorder Launched
8. Is Extreme Irritability - a Childhood Bipolar Disorder?
9. Antidepressant Medication Has No Effect on Bipolar Patients
10. Intensive Psychotherapy Effective in Treating Bipolar Disorder
11. Lithium Increases Gray Matter in Bipolar Brains
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/18/2017)... ... 18, 2017 , ... Mediaplanet today announces the launch of ... and highlighting the importance of proactive eye and ear health. The campaign focuses ... innovations in hearing aid technology. , In this issue, the American Speech-Language-Hearing ...
(Date:8/18/2017)... ... August 18, 2017 , ... The Dawn Johnson Insurance Group, ... new charity drive to generate community support for efforts to educate the local population ... treatments for all types of cancer. , Each day in America, roughly 4,600 ...
(Date:8/18/2017)... ... August 18, 2017 , ... Radabaugh & ... assistance to communities in North-Central West Virginia, is embarking on a cooperative charity ... in the area. , The Chestnut Mountain Ranch (CMR) is a Christ-centered boarding ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... planning assistance that serves communities throughout southern Florida, is working to support the ... assets to children from low income families. , The Take Stock In Children ...
(Date:8/18/2017)... (PRWEB) , ... August 18, 2017 , ... ... and financial planning firm that serves residential and commercial clients in the greater ... drive to raise community support for the fight against cancer. , Founded by ...
Breaking Medicine News(10 mins):
(Date:8/14/2017)... HACKENSACK, N.J. and PETACH TIKVAH, ... Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult ... for the second quarter ending June 30, 2017. ... advanced stages of preparing for our pivotal Phase 3 ... Chaim Lebovits , President and Chief Executive Officer ...
(Date:8/8/2017)... Israel, Aug. 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), ... today reports its financial results for the second quarter ... during the second quarter 2017 and to date: ... clinical development programs for the Company,s lead project, BL-8040: ... pivotal study with BL-8040 as novel stem cell mobilization ...
(Date:8/7/2017)... , Aug. 7, 2017 Zimmer Biomet Holdings, Inc. ... today announced that its Board of Directors has approved the ... third quarter of 2017. ... on or about October 27, 2017 to stockholders of record ... Future declarations of dividends are subject to approval of the ...
Breaking Medicine Technology: